MacBride-Stewart Sean, Marwick Charis, Houston Neil, Watt Iain, Patton Andrea, Guthrie Bruce
Division of Population Health Sciences, School of Medicine, University of Dundee, Dundee, Scotland.
Dollar Health Centre, Dollar, Clackmannanshire, Scotland.
Br J Gen Pract. 2017 May;67(658):e352-e360. doi: 10.3399/bjgp17X690437. Epub 2017 Mar 27.
It is uncertain whether improvements in primary care high-risk prescribing seen in research trials can be realised in the real-world setting.
To evaluate the impact of a 1-year system-wide phase IV prescribing safety improvement initiative, which included education, feedback, support to identify patients to review, and small financial incentives.
An interrupted time series analysis of targeted high-risk prescribing in all 56 general practices in NHS Forth Valley, Scotland, was performed. In 2013-2014, this focused on high-risk non-steroidal anti-inflammatory drugs (NSAIDs) in older people and NSAIDs with oral anticoagulants; in 2014-2015, it focused on antipsychotics in older people.
The primary analysis used segmented regression analysis to estimate impact at the end of the intervention, and 12 months later. The secondary analysis used difference-in-difference methods to compare Forth Valley changes with those in NHS Greater Glasgow and Clyde (GGC).
In the primary analysis, downward trends for all three NSAID measures that were existent before the intervention statistically significantly steepened following implementation of the intervention. At the end of the intervention period, 1221 fewer patients than expected were prescribed a high-risk NSAID. In contrast, antipsychotic prescribing in older people increased slowly over time, with no intervention-associated change. In the secondary analysis, reductions at the end of the intervention period in all three NSAID measures were statistically significantly greater in NHS Forth Valley than in NHS GGC, but only significantly greater for two of these measures 12 months after the intervention finished.
There were substantial and sustained reductions in the high-risk prescribing of NSAIDs, although with some waning of effect 12 months after the intervention ceased. The same intervention had no effect on antipsychotic prescribing in older people.
研究试验中所见到的初级保健高风险处方的改善是否能在现实环境中实现尚不确定。
评估一项为期1年的全系统IV期处方安全改善倡议的影响,该倡议包括教育、反馈、支持识别需复查的患者以及小额经济激励。
对苏格兰NHS福斯谷地区所有56家全科诊所的针对性高风险处方进行了中断时间序列分析。在2013 - 2014年,重点关注老年人使用的高风险非甾体抗炎药(NSAIDs)以及NSAIDs与口服抗凝剂的联用;在2014 - 2015年,重点关注老年人使用的抗精神病药物。
主要分析采用分段回归分析来估计干预结束时以及12个月后的影响。次要分析采用差异法来比较福斯谷地区与NHS大格拉斯哥和克莱德地区(GGC)的变化情况。
在主要分析中,干预实施后,干预前就已存在的所有三项NSAIDs指标的下降趋势在统计学上显著加剧。在干预期结束时,开具高风险NSAIDs处方的患者比预期少1221例。相比之下,老年人使用抗精神病药物的处方随时间缓慢增加,未出现与干预相关的变化。在次要分析中,干预结束时,NHS福斯谷地区三项NSAIDs指标的降幅在统计学上显著大于NHS GGC地区,但在干预结束12个月后,仅其中两项指标的降幅显著更大。
NSAIDs高风险处方有大幅且持续的减少,尽管在干预停止12个月后效果有所减弱。同样的干预对老年人使用抗精神病药物的处方没有影响。